CN1793927A - Reagent box for detecting clenbuterol hydrochloride and its detection method - Google Patents
Reagent box for detecting clenbuterol hydrochloride and its detection method Download PDFInfo
- Publication number
- CN1793927A CN1793927A CN 200510097304 CN200510097304A CN1793927A CN 1793927 A CN1793927 A CN 1793927A CN 200510097304 CN200510097304 CN 200510097304 CN 200510097304 A CN200510097304 A CN 200510097304A CN 1793927 A CN1793927 A CN 1793927A
- Authority
- CN
- China
- Prior art keywords
- cbl
- clenbuterol hydrochloride
- antibody
- solution
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OPXKTCUYRHXSBK-UHFFFAOYSA-N clenbuterol hydrochloride Chemical compound Cl.CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 OPXKTCUYRHXSBK-UHFFFAOYSA-N 0.000 title claims abstract description 29
- 229960001399 clenbuterol hydrochloride Drugs 0.000 title claims abstract description 28
- 238000001514 detection method Methods 0.000 title abstract description 23
- 239000003153 chemical reaction reagent Substances 0.000 title description 17
- 238000005406 washing Methods 0.000 claims abstract description 15
- 210000002700 urine Anatomy 0.000 claims abstract description 14
- 210000004369 blood Anatomy 0.000 claims abstract description 13
- 239000008280 blood Substances 0.000 claims abstract description 13
- 241001465754 Metazoa Species 0.000 claims abstract description 8
- 238000003018 immunoassay Methods 0.000 claims abstract description 7
- 239000000243 solution Substances 0.000 claims description 44
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 31
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 30
- 239000007788 liquid Substances 0.000 claims description 24
- 239000000427 antigen Substances 0.000 claims description 22
- 102000036639 antigens Human genes 0.000 claims description 22
- 108091007433 antigens Proteins 0.000 claims description 22
- 238000010790 dilution Methods 0.000 claims description 21
- 239000012895 dilution Substances 0.000 claims description 21
- 241000283707 Capra Species 0.000 claims description 19
- 239000011780 sodium chloride Substances 0.000 claims description 15
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 239000000872 buffer Substances 0.000 claims description 10
- 239000003480 eluent Substances 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 239000000047 product Substances 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 239000003995 emulsifying agent Substances 0.000 claims description 8
- 108010010803 Gelatin Proteins 0.000 claims description 7
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 claims description 7
- 238000004458 analytical method Methods 0.000 claims description 7
- 239000011248 coating agent Substances 0.000 claims description 7
- 238000000576 coating method Methods 0.000 claims description 7
- 230000002708 enhancing effect Effects 0.000 claims description 7
- 229920000159 gelatin Polymers 0.000 claims description 7
- 239000008273 gelatin Substances 0.000 claims description 7
- 235000019322 gelatine Nutrition 0.000 claims description 7
- 235000011852 gelatine desserts Nutrition 0.000 claims description 7
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 7
- 229920000053 polysorbate 80 Polymers 0.000 claims description 7
- 229910052693 Europium Inorganic materials 0.000 claims description 6
- 239000007853 buffer solution Substances 0.000 claims description 6
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 claims description 6
- 238000010521 absorption reaction Methods 0.000 claims description 5
- 229940092253 ovalbumin Drugs 0.000 claims description 5
- 239000007790 solid phase Substances 0.000 claims description 5
- ZMBHCYHQLYEYDV-UHFFFAOYSA-N trioctylphosphine oxide Chemical compound CCCCCCCCP(=O)(CCCCCCCC)CCCCCCCC ZMBHCYHQLYEYDV-UHFFFAOYSA-N 0.000 claims description 5
- WVVLURYIQCXPIV-UHFFFAOYSA-N 4,4,4-trifluoro-1-naphthalen-2-ylbutane-1,3-dione Chemical compound C1=CC=CC2=CC(C(=O)CC(=O)C(F)(F)F)=CC=C21 WVVLURYIQCXPIV-UHFFFAOYSA-N 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 4
- 238000011587 new zealand white rabbit Methods 0.000 claims description 4
- IWZKICVEHNUQTL-UHFFFAOYSA-M potassium hydrogen phthalate Chemical compound [K+].OC(=O)C1=CC=CC=C1C([O-])=O IWZKICVEHNUQTL-UHFFFAOYSA-M 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- 238000012360 testing method Methods 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000013504 Triton X-100 Substances 0.000 claims description 2
- 229920004890 Triton X-100 Polymers 0.000 claims description 2
- 229940098773 bovine serum albumin Drugs 0.000 claims description 2
- 230000003053 immunization Effects 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims 4
- 229960001117 clenbuterol Drugs 0.000 claims 4
- STJMRWALKKWQGH-UHFFFAOYSA-N clenbuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 STJMRWALKKWQGH-UHFFFAOYSA-N 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 2
- 230000000903 blocking effect Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 230000036046 immunoreaction Effects 0.000 claims 1
- 238000002372 labelling Methods 0.000 claims 1
- 238000003760 magnetic stirring Methods 0.000 claims 1
- 229960003330 pentetic acid Drugs 0.000 claims 1
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 4
- 230000008105 immune reaction Effects 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 238000013016 damping Methods 0.000 description 37
- 239000012530 fluid Substances 0.000 description 37
- 238000002360 preparation method Methods 0.000 description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 18
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000012856 packing Methods 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 7
- 238000004364 calculation method Methods 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 229910052747 lanthanoid Inorganic materials 0.000 description 3
- 150000002602 lanthanoids Chemical class 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241001597008 Nomeidae Species 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000006149 azo coupling reaction Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 102000014974 beta2-adrenergic receptor activity proteins Human genes 0.000 description 1
- 108040006828 beta2-adrenergic receptor activity proteins Proteins 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000012749 thinning agent Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
一种检测盐酸克伦特罗的试剂盒及其检测方法，属于时间分辨荧光免疫分析(TRFIA)技术领域，用于对动物性食品、血液及尿液中盐酸克伦特罗(CBL)含量的检测。本发明配制的试剂盒，微孔板包被有CBL－OVA，加入CBL标准或样品，再加入CBL抗体。游离的CBL与微孔板上的CBL－OVA竞争CBL抗体，没有连接的CBL抗体被洗涤除去，加入EU3+－羊抗兔抗体，标记免疫反应后没有连接的EU3+－羊抗兔抗体被洗涤除去。加增强液后，用时间分辨荧光仪测定其荧光强度cps，荧光强度与样品中的CBL浓度成反比，对照标准曲线即可确定被测样品中CBL的含量。本发明提供的检测CBL试剂盒结构简单，使用方便、廉价、灵敏度高，最低检测浓度为小于0.05ng/ml，相应的最低检测量为小于25ng/kg。
A kit for detecting clenbuterol hydrochloride and its detection method, which belong to the technical field of time-resolved fluorescent immunoassay (TRFIA), and are used for detecting the content of clenbuterol hydrochloride (CBL) in animal food, blood and urine detection. In the kit prepared by the invention, the micropore plate is coated with CBL-OVA, CBL standard or sample is added, and then CBL antibody is added. The free CBL competes with the CBL-OVA on the microwell plate for the CBL antibody, and the unlinked CBL antibody is washed away, and EU 3+ -goat anti-rabbit antibody is added to mark the unlinked EU 3+ -goat anti-rabbit antibody after the immune reaction removed by washing. After adding the enhancement solution, measure the fluorescence intensity cps with a time-resolved fluorometer. The fluorescence intensity is inversely proportional to the concentration of CBL in the sample, and the content of CBL in the tested sample can be determined by comparing with the standard curve. The detection kit for CBL provided by the invention has the advantages of simple structure, convenient use, low cost and high sensitivity, the minimum detection concentration is less than 0.05ng/ml, and the corresponding minimum detection amount is less than 25ng/kg.
Description
Technical field
A kind of kit and detection method thereof that detects clenobuterol hydrochloride belongs to time resolved fluoro-immunoassay (TRFIA) technical field, is used for the detection to animal food, blood and urine clenobuterol hydrochloride (being called for short CBL) content.
Background technology
Clenobuterol hydrochloride (CBL) is a kind of beta-2-adrenoceptor activator, clinically as the bronchus spasmolysis medicine, bronchial smooth muscle β-2 acceptor is had excitation.Studies show that clenobuterol hydrochloride can strengthen the steatolysis and the protein catabolism that slows down, so if heavy dose of use in herding is produced can obviously be improved food conversion ratio and lean meat percentage, clenbuterol hydrochloride therefore is otherwise known as.If but using dosage is excessive, then can produce sizable toxic action to liver, the kidney and other organs of animal and human's (indirectly), dizziness, palpitaition, expiratory dyspnea, muscular tremor, toxicity symptoms such as headache appear palpitating quickly.Clenobuterol hydrochloride also can enter to produce in the fetus body by placental barrier to be accumulated, thereby filial generation is produced serious harm.
European Union forbade in 1996 using this medicine (EC Directive 96/22/EC) in herding is produced, and identical regulation was also made by China Ministry of Agriculture in 1997.However, because ordering about of economic interests uses this phenomenon of clenobuterol hydrochloride to still have generation at present, extensive poisoning all takes place every year in herding is produced.The pollution of clenobuterol hydrochloride has caused the fear of people to foodsafety.Current, causing one of reason that clenbuterol hydrochloride remains incessant after repeated prohibition is exactly also imperfection of the method that detects clenobuterol hydrochloride both at home and abroad, means, and the problem of existence mainly contains: sensitivity is not high, and accuracy is not enough; Poor specificity, technical sophistication can not spread to basic unit.
The detection method of clenobuterol hydrochloride mainly contains at present: chromatographic technique and immuno analytical method.Chromatographic technique (HPLC, GC-MS, LC-MS) is because time-consuming, and cost is many, is subjected to certain limitation in actual applications, usually as deterministic quantitative test method; Immuno analytical method (ELISA) is the scene sampling rapid screening method of inspection of using always, at present, China imports and exports inspection and quarantine, the German R-Biopharm of the many employings in veterinary hygiene department and slaughterhouse, the clenobuterol hydrochloride ELISA detection kit that companies such as Britain Randox produce, but, limited its usable range to a certain extent because the import reagent box costs an arm and a leg.Problems such as homemade ELISA kit ubiquity insufficient sensitivity, false positive rate height, instability.
Time resolved fluoro-immunoassay method (TRFIA) is the new immunoassay that last century, early eighties grew up.Its principle of time resolved fluoro-immunoassay method is to utilize the sequestrant with bifunctional group structure, one end and lanthanide series combination, and the free amino group on the other end and the antibody molecule connects, and makes EU
3+Antigen in the labelled antibody, it and testing sample is combined into immune complex.Ideally, the fluorescence intensity of measuring lanthanide series in the compound just can be determined the amount of antigen in the sample, but the fluorescence intensity of in fact this compound quite a little less than, have only and add a kind of enhancing solution (Enhancement solution) again, lanthanide series is disintegrated down from compound, and with strengthen β-naphthoyltrifluoroacetone contained in the liquid (β-NTA) form microcapsules again, the very strong fluorescence of emission under the exciting of light such as ultraviolet, up to a million times of enhancing effects.Differentiate luminoscope with the time and measure its fluorescence intensity cps, can determine the amount of antigen in the sample.
Summary of the invention
The object of the present invention is to provide kit and the detection method thereof of a kind of CBL of detection, be used for detection animal food, blood and urine CBL content.
Technical scheme of the present invention: the kit of this detection CBL be by 1.96 or 48 holes bags by plate, 2. damping fluid, 3. clenobuterol hydrochloride standard, the antibody dried frozen aquatic products of 4 clenobuterol hydrochlorides, the 5. goat anti-rabbit antibody of europium mark, 6. cleansing solution 7. strengthens liquid and forms.
Bag is by plate (1): bag is used 50mmol/L pH9.6Na by solid phase antigen
2CO
3-NaHCO
3Damping fluid clenobuterol hydrochloride-ovalbumin is diluted to 1mg/L as coating buffer, 96 or 48 each hole of hole microwell plate add 100 μ l, 4 ℃ of placements are spent the night, discard coating buffer, wash three times, add the damping fluid sealing of Tris-HCl that 200 μ l contain the 50mmol/LpH7.2 of mass concentration 0.2% gelatin, 4 ℃ of placements are spent the night, discard confining liquid, vacuum is drained, rearmounted-20 ℃ of freezing preservations of lath sealing;
Damping fluid (2): 8mmol/L NaCl, mass concentration 0.1% gelatin, 50 μ mol/L diethylene triamine pentacetic acid (DTPA)s, 0.1ml/L Tween-80 and contain mass concentration 0.1%NaN
350mmol/L Tris-HCl pH7.8;
Clenobuterol hydrochloride standard (3): totally 6 bottles, clenobuterol hydrochloride concentration is respectively: 0ng/ml, and 0.05ng/ml, 0.25ng/ml, 1ng/ml, 5ng/ml, 25ng/ml, dilution are the PBS of pH7.4 10mmol/L;
The antibody dried frozen aquatic products (4) of clenobuterol hydrochloride: with Freund's complete adjuvant or incomplete Freund 1.2ml mixing 2mg clenobuterol hydrochloride-bovine serum albumin(BSA), mixed 2 hours with homogenizer, make Water-In-Oil antigen emulsifying agent, get the Water-In-Oil antigen emulsifying agent that 600 μ l prepare, multidigit point ground carries out hypodermic injection on one's body new zealand white rabbit, after immunity 3～4 times, serum identifies, qualified back dilution, packing, freeze-drying are standby;
The goat anti-rabbit antibody of europium mark (5): get the 5g/L goat anti-rabbit antibody 1-2ml that is dissolved in 50mmol/L PBS pH7.0, through the conversion buffered condition of PD-10 post, eluent is the 50mmol/LNa that contains 0.155mol/L NaCl
2CO
3-NaHCO
3The pH8.5-9.0 damping fluid is collected protein peak, and is quantitative through the uv absorption analysis, and to 2g/L, the goat anti-rabbit antibody of getting after 500-1000 μ l dilutes adds the Eu that contains 0.2-0.4mg with above-mentioned eluent dilution goat anti-rabbit antibody
3+-N
2In the bottle of-[p-isocyanic acid-benzyl]-diethylenetriamine tetraacethyl, 28-30 ℃ of magnetic agitation reacted 16-20 hour, reactant liquor is collected protein peak through the 1 * 40cmSephadex-G50 column chromatography with 80mmol/L Tris-HCl pH7.8 damping fluid balance, and dilution, packing are standby;
Cleansing solution (6): 14.5mmol/L NaCl, 0.2ml/L Tween-80 and contain mass concentration 0.2%NaN
350mmol/L Tris-HCl pH7.8;
Strengthen liquid (7): 1 liter of pH3.2 Potassium Hydrogen Phthalate damping fluid contains 15 μ mol β-naphthoyltrifluoroacetones, 50 μ mol trioctyl-phosphine oxide and 1ml triton x-100.
The present invention mainly adopts time resolved fluoro-immunoassay method (TRFIA) to detect CBL.Adopt the technology of TRFIA to mainly contain two aspects: the preparation of specific polyclonal antibody, utilize the antigen immune rabbit, obtain to contain the serum of antibody, through biochemical purification separating immune globulin; The second, EU
3+The preparation of labelled antibody.
Assay method is: the basis of mensuration is the labelled immune reaction.Be coated with the microwell plate of CBL-OVA, the sample that adds the CBL standard or handled well in micropore separately, add CBL antibody again, oscillating reactions, free CBL and the CBL-OVA on the microwell plate compete CBL antibody, the cleansing solution washing, the CBL antibody that does not have to connect is removed in washing step.Add EU
3+-goat anti-rabbit antibody carries out the labelled immune reaction, and with the cleansing solution washing, the reaction back does not have the EU of connection again
3+-goat anti-rabbit antibody is removed in washing step.After adding the vibration of enhancing liquid, the very strong fluorescence of emission under the exciting of ultraviolet light is differentiated luminoscope with the time and is measured its fluorescence intensity cps, and the CBL concentration in fluorescence intensity and the sample is inversely proportional to, the clenobuterol hydrochloride content in the reference standard curve calculation sample.
It is operating as: get be coated with clenobuterol hydrochloride-ovalbumin the micropore bag by plate, the sample that adds the clenobuterol hydrochloride standard of 50 μ l or handled well is in micropore separately, add with damping fluid (2) and make thinning agent, 50 μ l antibody of clenbuteral hydrochloride after diluting 20 times at 1: 20,25-37 ℃ vibrated 0.5-1 hour, cleansing solution is given a baby a bath on the third day after its birth time, adds with 100 μ l EU after 20 times of damping fluid (2) dilutions in 1: 20
3+-goat anti-rabbit antibody, 25-37 ℃ vibrated 0.5-1 hour, washed six times with cleansing solution, added the vibration of 200 μ l enhancing liquid and measured fluorescence intensity cps, the content of clenobuterol hydrochloride in the reference standard curve calculation sample after 5 minutes.
Sample preparation, animal tissue's sample preparation: with reference to GB/T5009.192-2003; Blood sample is handled: gets the PBS that 0.5ml blood adds 0.5mlpH7.4 10mmol/L and dilutes, and standby; Urine sample is handled: limpid pig urine sample is diluted more than 10 times with the PBS of pH7.4 10mmol/L, and is standby, if the urine sample muddiness must be filtered or be centrifugal, gets filtrate or supernatant and dilutes back standby.
Beneficial effect of the present invention: this kit is simple in structure, and is easy to use, cheap, highly sensitive, and minimal detectable concentration is less than 0.05ng/ml, and corresponding lowest detection amount is less than 25ng/kg.
Description of drawings
Fig. 1: the kit synoptic diagram that detects clenobuterol hydrochloride.1.96 or 48 holes bags is by plate, 2. damping fluid, and 3. clenobuterol hydrochloride standard, the 4. antibody dried frozen aquatic products of clenobuterol hydrochloride, the 5. goat anti-rabbit antibody of europium mark, 6. cleansing solution 7. strengthens liquid.
Fig. 2: CBL-TRFIA canonical plotting.
Embodiment
Embodiment 1 preparation kit and detection liver sample
CBL is typical haptens, thus in immune response, have reactionogenicity, but need and immunogenicity is just arranged after macromolecular substances combines, the carboxyl among the CBL is a reactive group, can combine with the amino of protein.Therefore available diazo coupling method makes CBL combine with high molecular weight protein bovine serum albumin(BSA) (BSA), carries out animal immune with the CBL-BSA that synthesizes as the immunizing antigen of synthetic.
The preparation of CBL-BSA antigen: 3-6mgCBL is dissolved among the HCl of 100mmol/L precooling, slowly drips the 1mol/L sodium nitrite solution, checks when test paper becomes darkviolet with the KI starch paper to stop, and obtains the diazotising derivant.Taking by weighing 10-20mgBSA is dissolved in the carbonate buffer solution of pH9.650mmol/L.Diazotizing CBL is slowly splashed in the BSA solution, regulate pH with 1mol/LNaOH and maintain 9.0～9.5, after dripping end, continue reaction 4 hours, phosphate buffer (PBS) with pH7.4 10mmol/L in 4 ℃ of refrigerators was dialysed two days, obtain the CBL-BSA bond and carry out the UV scanning detection, qualified back packing is standby.
The preparation of polyclone antibody of clenbuteral hydrochloride:
1. it is big to choose for 4 weeks, the healthy new zealand white rabbit of the about 1.5Kg of body weight.CBL is a kind of haptens, and CBL is connected as antigen with BSA.
The preparation of 2 Water-In-Oil antigen emulsifying agents:, made Water-In-Oil antigen emulsifying agent in 2 hours with the homogenizer mixing with Freund's complete adjuvant or incomplete Freund 1.2ml mixing 2mgCBL-BSA.The emulsifying agent that makes is splashed in the beaker that fills cold water, and an oil droplet state can intactly rest on the water surface, and indiffusion shows it is stable.
3. immune rabbit and blood drawing: the hair with the rabbit back carefully cuts off earlier, get the Water-In-Oil antigen emulsifying agent that 600 μ l prepare then, multidigit point ground carries out hypodermic injection on one's body new zealand white rabbit, antigen can slowly be spread, every 1～2 all immunity once, need six times altogether, after immunity 3～4 times, from the about 1ml of auricular vein blood drawing of rabbit, behind the centrifugal 10min, getting serum can identify.The dilution of qualified back, packing, freeze-drying are standby.
Eu
3+The preparation of-goat anti-rabbit antibody:
Get the 5g/L goat anti-rabbit antibody 1-2ml that is dissolved in 50mmol/L PBS pH7.0, through the conversion buffered condition of PD-10 post, eluent is the 50mmol/L Na that contains 0.155mol/L NaCl
2CO
3-NaHCO
3The pH8.5 damping fluid.Collect protein peak, through the quantitative (1.46A of uv absorption analysis
280-0.74A
260), dilute goat anti-rabbit antibody to 2g/L with above-mentioned eluent.The goat anti-rabbit antibody of getting after 500-1000 μ l dilutes adds the Eu that contains 0.2-0.4mg
3+-N
2-[p-isocyanic acid-benzyl]-diethylenetriamine tetraacethyl (Eu
3+In-DTTA) the bottle, 30 ℃ of magnetic agitation reactions 20 hours.Reactant liquor is through Sepharose CL-6B post (1 * 40cm) chromatography, A with 80mmol/L Tris-HCl pH7.8 damping fluid balance
280Protein peak is collected in monitoring, and the dilution packing is standby.
Bag is prepared by the plate solid phase antigen:
Use 50mmol/L Na
2CO
3-NaHCO
3The pH9.6 damping fluid is diluted to 1mg/L as coating buffer with CBL-BSA, and each hole of microwell plate, 96 (or 48) hole adds 100 μ l, and 4 ℃ of placements are spent the night.Discard coating buffer, wash three times, add the damping fluid sealing of Tris-HCl that 200 μ l contain the 50mmol/LpH7.2 of mass concentration 0.2% gelatin, 4 ℃ of placements are spent the night.Discard confining liquid, vacuum is drained, rearmounted-20 ℃ of freezing preservations of lath sealing.
The preparation of reagent:
(1) clenobuterol hydrochloride standard, totally 6 bottles, concentration is respectively: 0ng/ml, 0.05ng/ml, 0.25ng/ml, 1ng/ml, 5ng/ml, 25ng/ml, dilution are the PBS of pH7.4 10mmol/L.
(2) damping fluid: 8mmol/L NaCl, mass concentration 0.1% gelatin, 50 μ mol/L diethylene triamine pentacetic acid (DTPA)s, 0.1ml/L Tween-80 and contain mass concentration 0.1%NaN
350mmol/L Tris-HCl pH7.8.
(3) cleansing solution: 14.5mmol/L NaCl, 0.2ml/L Tween-80 and contain mass concentration 0.2%NaN
350mmol/L Tris-HCl pH7.8.
(4) strengthen the preparation of liquid: 1 liter of pH3.2 Potassium Hydrogen Phthalate damping fluid contains 15 μ mol β-naphthoyltrifluoroacetones (β-NTA), 50 μ mol trioctyl-phosphine oxide (TOPO), 1ml triton x-100 (TritonX-100).
The reagent that kit provides
Reagent in each box enough carries out 96 measurements, and the material in the box is as follows:
(1) .1 * 96 orifice plates (8 * 12 hole can be split as single hole) are coated with CBL-OVA.
(2) .6 * CBL titer, the 1.0ml/ bottle, concentration of standard solution is: 0,0.05,0.25,1,5,25ng/ml.
(3) .1 * CBL antibody dried frozen aquatic products, time spent 0.5ml dissolved in distilled water.
(4) .1 * EU
3+-goat anti-rabbit antibody dried frozen aquatic products, time spent 0.5ml dissolved in distilled water.
(5) .1 * enhancing liquid: 15ml.
(6) .1 * cleansing solution: 30ml, the time spent is with distilled water dilution in 1: 25.
(7) .1 * damping fluid: 30ml,
The reagent that the laboratory should be provided for oneself
Perchloric acid
Isopropyl alcohol
Ethyl acetate
Perchloric acid solution (0.1mol/L)
Sodium hydroxide solution (1mol/L)
The PBS damping fluid (pH7.4,0.01mol/L)
Isopropyl alcohol+ethyl acetate (volume ratio 40+60)
Distilled water or deionized water.
Points for attention before measuring
1. before using all reagent are gone up to room temperature (18-30 ℃).
2. immediately all reagent are put back to 2-8 ℃ after using.
3. if the hyperchannel pipettor is used in the big suggestion of sample size.
4. hatch in the process at all constant temperature, avoid irradiate light, use the cap covers micropore.
5. taking-up needs microwell plate and the framework with quantity, no microwell plate is put in the former Fresco Bag and with the drying agent that provides reseal, and is stored in 2-8 ℃.
Concrete detection step is as follows:
Earlier sample is handled: animal tissue's sample preparation, with reference to GB/T5009.192-2003.Take by weighing liver sample 10g (being accurate to 0.01g), with the homogenate of 20mL0.1mol/L perchloric acid solution, place the grournd glass centrifuge tube, place the ultrasonic 20min of ultrasonic cleaner then, taking-up places 80 ℃ of water-baths to heat 30min, takes out cooling back centrifugal (4500r/min) 15min.Inclining supernatant, and precipitation is with the washing of 5mL0.1mol/L perchloric acid solution, and is centrifugal again, and twice supernatant is merged.With 1mol/L sodium hydroxide solution adjust pH to 9.5 ± 0.1, if there is precipitation to produce, centrifugal again (4500r/min) 10min, supernatant is transferred in the grournd glass centrifuge tube, add 8g sodium chloride, mixing adds 25mL isopropyl alcohol+ethyl acetate (volume ratio 40+60), places oscillation extraction 20min on the oscillator.Extraction finishes, and places 5min (once centrifugal slightly as if emulsion layer is arranged).Carefully upper organic phase is moved in the rotary evaporation bottle with suction pipe, usefulness 20mL isopropyl alcohol+ethyl acetate (40+60) re-extract more once merges organic phase, is concentrated near doing in 60 ℃ on rotary evaporator.With the abundant dissolution residual substance of 1mL pH7.4 10mmol/LPBS damping fluid.Through syringe-type micro porous filtration membrane filtration, be transferred to fully in the 5mL glass centrifuge tube after washing three times, and be settled to scale with pH7.4 10mmol/LPBS damping fluid, standby.
Get the CBL-OVA lath, the sample that adds the CBL standard of 50 μ l or handle well is in micropore separately, each standard and sample must use new suction nozzle, CBL antibody 50 μ l with damping fluid dilution in 1: 20, the pipettor tip must not touch the liquid of putting in the hole, 25 ℃ vibrated 1 hour, and cleansing solution is given a baby a bath on the third day after its birth inferior, with the EU of damping fluid dilution in 1: 20
3+-goat anti-rabbit antibody 100 μ l, 25 ℃ vibrated 1 hour, washed six times with cleansing solution, added 200 μ l and strengthened liquid vibration measurement after 5 minutes.CBL content from the typical curve calculation sample sees Table 1 and Fig. 2, and CBL concentration is 0.09ng/ml in this routine sample.
Table 1
| The CBL standard point | |||||||
| CB concentration (ng/ml) | 0 | 0.05 | 0.25 | 1 | 5 | 25 | The liver sample |
| Fluorescent value (cps) | 1584332 | 1422259 | 1296643 | 1029912 | 724388 | 364570 | 1388136 |
The preparation of CBL-BSA antigen: with embodiment 1.
The preparation of polyclone antibody of clenbuteral hydrochloride: with embodiment 1.
Eu
3+The preparation of-goat anti-rabbit antibody:
Get the 5g/L goat anti-rabbit antibody 1ml that is dissolved in 50mmol/L PBS pH7.0, through the conversion buffered condition of PD-10 post, eluent is the 50mmol/L Na that contains 0.155mol/L NaCl
2CO
3-NaHCO
3The pH9.0 damping fluid.Collect protein peak, through the quantitative (1.46A of uv absorption analysis
280-0.74A
260), dilute goat anti-rabbit antibody to 2g/L with above-mentioned eluent.Get 500 μ l and add the Eu that contains 0.2mg
3+-N
2-[p-isocyanic acid-benzyl]-diethylenetriamine tetraacethyl (Eu
3+In-DTTA) the bottle, 28 ℃ of magnetic agitation reactions 16 hours.(1 * 40cm) chromatography is collected protein peak to reactant liquor, and the dilution packing is standby through the Sephadex-G50 post with 80mmol/L Tris-HClpH7.8 damping fluid balance.
Bag is prepared by the plate solid phase antigen: with example 1.
The preparation of reagent:
1. clenobuterol hydrochloride standard: 0ng/ml, 0.05ng/ml, 0.25g/ml, 1ng/ml, 5ng/ml, 25ng/ml.
2. damping fluid: 8mmol/L NaCl, mass concentration 0.1% gelatin, 50 μ mol/L diethylene triamine pentacetic acid (DTPA)s, 0.1ml/L Tween-80 and contain mass concentration 0.1%NaN
350mmol/L Tris-HCl pH7.8
3. cleansing solution: 14.5mmol/L NaCl, 0.2ml/L Tween-20 and contain mass concentration 0.2%NaN
350mmol/L Tris-HCl pH7.8.
4. strengthen the preparation of liquid: 1 liter of pH3.2 Potassium Hydrogen Phthalate damping fluid contains 15 μ mol β-NTA, 50 μ mol TOPO, 1ml Triton X-100.
The reagent that kit provides
Reagent in each box enough carries out 48 measurements, and the material in the box is as follows:
(1) .1 * 48 orifice plates (4 * 12 hole can be split as single hole) are coated with CBL-OVA.
(2) .6 * CBL titer, the 1.0ml/ bottle, concentration of standard solution is: 0,0.05,0.25,1,5,25ng/ml.
(3) .1 * CBL antibody dried frozen aquatic products, time spent 0.5ml dissolved in distilled water.
(4) .1 * EU
3+-goat anti-rabbit antibody dried frozen aquatic products, time spent 0.5ml dissolved in distilled water.
(5) .1 * enhancing liquid: 15ml.
(6) .1 * cleansing solution: 30ml, the time spent is with distilled water dilution in 1: 25.
(7) .1 * damping fluid: 30ml.
The preparation of CBL-BSA antigen: 6mgCBL is dissolved among the HCl of 100mmol/L precooling, slowly drips the 1mol/L sodium nitrite solution, checks when test paper becomes darkviolet with the KI starch paper to stop, and obtains the diazotising derivant.Taking by weighing 20mgBSA is dissolved in the carbonate buffer solution of pH9.650mmol/L.Diazotizing CBL is slowly splashed in the BSA solution, regulate pH with 1mol/LNaOH and maintain 9.0～9.5, after dropping finishes, continue reaction 4 hours, PBS with pH7.410mmol/L in 4 ℃ of refrigerators dialysed two days, obtained the CBL-BSA bond and carried out the UV scanning detection, and qualified back packing is standby.
The preparation of polyclone antibody of clenbuteral hydrochloride is identical with embodiment 1, slightly.
Eu
3+The preparation of-goat anti-rabbit antibody:
Get the 5g/L goat anti-rabbit antibody 2ml that is dissolved in 50mmol/L PBS pH7.0, through the conversion buffered condition of PD-10 post, eluent is the 50mmol/L Na that contains 0.155mol/L NaCl
2CO
3-NaHCO
3The pH8.5 damping fluid.Collect protein peak, through the quantitative (1.46A of uv absorption analysis
280-0.74A
260), dilute goat anti-rabbit antibody to 2g/L with above-mentioned eluent.Get 1000 μ l and add the Eu that contains 0.4mg
3+-N
2-[p-isocyanic acid-benzyl]-diethylenetriamine tetraacethyl (Eu
3+In-DTTA) the bottle, 30 ℃ of magnetic agitation reactions 20 hours.Reactant liquor is through Sepharose CL-6B post (1 * 40cm) chromatography, A with 80mmol/L Tris-HClpH7.8 damping fluid balance
280Protein peak is collected in monitoring, and the dilution packing is standby.
The solid phase antigen preparation is identical with embodiment 1.
The preparation of reagent is identical with embodiment 1.
The reagent that kit provides is identical with embodiment 1.
The reagent that the laboratory should be provided for oneself is identical with embodiment 1.
Points for attention are with embodiment 1 before measuring.
The concrete step that detects is with embodiment 1.
Embodiment 4
The reagent that kit provides is identical with embodiment 1, is used to detect muscle samples.
Concrete detection step is as follows:
Earlier sample is handled: take by weighing muscle samples 10g (being accurate to 0.01g), with the homogenate of 20mL0.1mol/L perchloric acid solution, place the grournd glass centrifuge tube, place the ultrasonic 20min of ultrasonic cleaner then, taking-up places 80 ℃ of water-baths to heat 30min, takes out cooling back centrifugal (4500r/min) 15min.Inclining supernatant, and precipitation is with the washing of 5mL0.1mol/L perchloric acid solution, and is centrifugal again, and twice supernatant is merged.With 1mol/L sodium hydroxide solution adjust pH to 9.5 ± 0.1, if there is precipitation to produce, centrifugal again (4500r/min) 10min, supernatant is transferred in the grournd glass centrifuge tube, add 8g sodium chloride, mixing adds 25mL isopropyl alcohol+ethyl acetate (40+60), places vibration extraction 20min on the oscillator.Extraction finishes, and places 5min (once centrifugal slightly as if emulsion layer is arranged).Carefully upper organic phase is moved in the rotary evaporation bottle with suction pipe, usefulness 20mL isopropyl alcohol+ethyl acetate (40+60) re-extract more once merges organic phase, is concentrated near doing in 60 ℃ on rotary evaporator.With the abundant dissolution residual substance of 1mL pH7.4 0.01mol/LPBS damping fluid.Through syringe-type micro porous filtration membrane filtration, be transferred to fully in the 5mL glass centrifuge tube after washing three times, and be settled to scale with pH7.4 0.01mol/LPBS damping fluid, standby.
Get the CBL-OVA lath, the sample that adds the CBL standard of 50 μ l or handle well is in micropore separately, each standard and sample must use new suction nozzle, CBL antibody 50 μ l with damping fluid dilution in 1: 20, the pipettor tip must not touch the liquid of putting in the hole, 37 ℃ vibrated 0.5 hour, and cleansing solution is given a baby a bath on the third day after its birth inferior, with the EU of damping fluid dilution in 1: 20
3+-goat anti-rabbit antibody 100 μ l, 37 ℃ vibrated 0.5 hour, washed six times with cleansing solution, added 200 μ l and strengthened liquid vibration measurement after 5 minutes.CBL content from the typical curve calculation sample sees Table 2 and Fig. 2, and CBL concentration is .0.03ng/ml in this routine sample.
Table 2
| The CBL standard point | |||||||
| CBL concentration (ng/ml) | 0 | 0.05 | 0.25 | 1 | 5 | 25 | Muscle samples |
| Fluorescent value (cps) | 1584332 | 1422259 | 1296643 | 1029912 | 724388 | 364570 | 1442482 |
The reagent that kit provides is identical with embodiment 1, is used to detect blood sample.
Concrete detection step is as follows:
Earlier blood sample is handled: get the PBS that 0.5ml blood adds 0.5mlpH7.4 10mmol/L and dilute, standby.
Get the CBL-OVA lath, the sample that adds the CBL standard of 50 μ l or handle well is in micropore separately, each standard and sample must use new suction nozzle, CBL antibody 50 μ l with damping fluid dilution in 1: 20, the pipettor tip must not touch the liquid of putting in the hole, 25 ℃ vibrated 1 hour, and cleansing solution is washed 3 times, with the EU of damping fluid dilution in 1: 20
3+-goat anti-rabbit antibody 100 μ l, 37 ℃ vibrated 0.5 hour, washed 6 times with cleansing solution, added 200 μ l and strengthened liquid vibration measurement after 5 minutes.CBL content from the typical curve calculation sample sees Table 3 and Fig. 2, and CBL concentration is 2.01ng/ml in this routine sample.
Table 3
| The CBL standard point | |||||||
| CBL concentration (ng/ml) | 0 | 0.05 | 0.25 | 1 | 5 | 25 | Blood sample |
| Fluorescent value (cps) | 1584332 | 1422259 | 1296643 | 1029912 | 724388 | 364570 | 906071 |
The reagent that kit provides is identical with embodiment 1, is used to detect urine sample.
Concrete detection step is as follows:
Earlier urine sample is handled: limpid pig urine is diluted more than 10 times with the PBS of pH7.4 10mmol/L, and is standby.If the urine sample muddiness must be filtered or be centrifugal, get filtrate or supernatant and dilute back standby.
Get the CBL-OVA lath, the sample that adds the CBL standard of 50 μ l or handle well is in micropore separately, each standard and sample must use new suction nozzle, CBL antibody 50 μ l with damping fluid dilution in 1: 20, the pipettor tip must not touch the liquid of putting in the hole, 25 ℃ vibrated 1 hour, and cleansing solution is washed 3 times, with the EU of damping fluid dilution in 1: 20
3+-goat anti-rabbit antibody 100 μ l, 37 ℃ vibrated 0.5 hour, washed 6 times with cleansing solution, added 200 μ l and strengthened liquid vibration measurement after 5 minutes.CBL content from the typical curve calculation sample sees Table 4 and Fig. 2, and CBL concentration is 0.47ng/ml in this routine sample.
Table 4
| The CBL standard point | |||||||
| CBL concentration (ng/ml) | 0 | 0.05 | 0.25 | 1 | 5 | 25 | Urine sample |
| Fluorescent value (cps) | 1584332 | 1422259 | 1296643 | 1029912 | 724388 | 364570 | 1183804 |
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510097304 CN1793927A (en) | 2005-12-31 | 2005-12-31 | Reagent box for detecting clenbuterol hydrochloride and its detection method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510097304 CN1793927A (en) | 2005-12-31 | 2005-12-31 | Reagent box for detecting clenbuterol hydrochloride and its detection method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1793927A true CN1793927A (en) | 2006-06-28 |
Family
ID=36805494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510097304 Pending CN1793927A (en) | 2005-12-31 | 2005-12-31 | Reagent box for detecting clenbuterol hydrochloride and its detection method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1793927A (en) |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101713783A (en) * | 2009-12-04 | 2010-05-26 | 江苏省微生物研究所有限责任公司 | Detection kit and detection method of dienestrol |
| CN101750502A (en) * | 2008-12-19 | 2010-06-23 | 上海交通大学医学院附属仁济医院 | TRFIA for synchronously detecting AFP and AFP-IgM and reagent kit thereof |
| CN101799469A (en) * | 2010-03-17 | 2010-08-11 | 北京阿匹斯生物技术有限公司 | Enzyme linked immunosorbent assay kit for detecting residual clenbuterol hydrochloride and a detection method thereof |
| CN101825639A (en) * | 2010-05-06 | 2010-09-08 | 北京中诚晶创医药科技有限公司 | Kit for diagnosing common fetal chromosome abnormality and preparation method thereof |
| CN101936984A (en) * | 2010-08-03 | 2011-01-05 | 中国农业大学 | A method for detecting clenbuterol and its special chemiluminescence immunoassay kit |
| CN101324574B (en) * | 2008-07-16 | 2012-04-18 | 江苏省原子医学研究所 | Method for detecting wash residual interference in time resolved fluorescent immune analysis |
| CN102464719A (en) * | 2010-11-11 | 2012-05-23 | 中国科学院上海生命科学研究院 | Murine anti-clenbuterol monoclonal antibody and application thereof |
| CN102759622A (en) * | 2011-04-28 | 2012-10-31 | 宝瑞源生物技术(北京)有限公司 | Nitrofurans drug metabolite assay kit and production method thereof |
| CN103012593A (en) * | 2011-09-21 | 2013-04-03 | 北京勤邦生物技术有限公司 | Preparation and applications of clenbuterol monoclonal antibody |
| CN104090248A (en) * | 2013-12-24 | 2014-10-08 | 上海容晖生物科技有限公司 | Reagent for quantitative detection of Beta-receptor stimulant through Europium chelate latex time-resolved immunochromatographic assay |
| CN104914080A (en) * | 2015-05-14 | 2015-09-16 | 桂林理工大学 | Rapid detection method of clenbuterol |
| CN103012593B (en) * | 2011-09-21 | 2016-12-14 | 北京勤邦生物技术有限公司 | The preparation of clenbuterol monoclonal antibody and application thereof |
| CN106996971A (en) * | 2017-04-28 | 2017-08-01 | 江南大学 | Detect the kit and method of human peripheral EVs TRPC5 contents |
| CN107884567A (en) * | 2017-12-08 | 2018-04-06 | 广州源起健康科技有限公司 | A kind of magnetic bead time-resolved fluoroimmunoassay quantitatively detects Clenbuterol kit |
| CN110183474A (en) * | 2019-06-13 | 2019-08-30 | 辽宁大学 | A kind of novel fluorescence probe and preparation method thereof and in detection urine " clenbuterol hydrochloride " clenbuterol application |
-
2005
- 2005-12-31 CN CN 200510097304 patent/CN1793927A/en active Pending
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101324574B (en) * | 2008-07-16 | 2012-04-18 | 江苏省原子医学研究所 | Method for detecting wash residual interference in time resolved fluorescent immune analysis |
| CN101750502A (en) * | 2008-12-19 | 2010-06-23 | 上海交通大学医学院附属仁济医院 | TRFIA for synchronously detecting AFP and AFP-IgM and reagent kit thereof |
| CN101713783A (en) * | 2009-12-04 | 2010-05-26 | 江苏省微生物研究所有限责任公司 | Detection kit and detection method of dienestrol |
| CN101799469A (en) * | 2010-03-17 | 2010-08-11 | 北京阿匹斯生物技术有限公司 | Enzyme linked immunosorbent assay kit for detecting residual clenbuterol hydrochloride and a detection method thereof |
| CN101825639A (en) * | 2010-05-06 | 2010-09-08 | 北京中诚晶创医药科技有限公司 | Kit for diagnosing common fetal chromosome abnormality and preparation method thereof |
| CN101936984B (en) * | 2010-08-03 | 2013-10-16 | 中国农业大学 | Method and special chemical luminous immunoassay kit for detecting clenbuterol |
| CN101936984A (en) * | 2010-08-03 | 2011-01-05 | 中国农业大学 | A method for detecting clenbuterol and its special chemiluminescence immunoassay kit |
| CN102464719B (en) * | 2010-11-11 | 2014-06-04 | 中国科学院上海生命科学研究院 | Murine anti-clenbuterol monoclonal antibody and its application |
| CN102464719A (en) * | 2010-11-11 | 2012-05-23 | 中国科学院上海生命科学研究院 | Murine anti-clenbuterol monoclonal antibody and application thereof |
| CN102759622A (en) * | 2011-04-28 | 2012-10-31 | 宝瑞源生物技术(北京)有限公司 | Nitrofurans drug metabolite assay kit and production method thereof |
| CN103012593A (en) * | 2011-09-21 | 2013-04-03 | 北京勤邦生物技术有限公司 | Preparation and applications of clenbuterol monoclonal antibody |
| CN103012593B (en) * | 2011-09-21 | 2016-12-14 | 北京勤邦生物技术有限公司 | The preparation of clenbuterol monoclonal antibody and application thereof |
| CN104090248A (en) * | 2013-12-24 | 2014-10-08 | 上海容晖生物科技有限公司 | Reagent for quantitative detection of Beta-receptor stimulant through Europium chelate latex time-resolved immunochromatographic assay |
| CN104914080A (en) * | 2015-05-14 | 2015-09-16 | 桂林理工大学 | Rapid detection method of clenbuterol |
| CN104914080B (en) * | 2015-05-14 | 2017-04-26 | 桂林理工大学 | Rapid detection method of clenbuterol |
| CN106996971A (en) * | 2017-04-28 | 2017-08-01 | 江南大学 | Detect the kit and method of human peripheral EVs TRPC5 contents |
| WO2018196544A1 (en) * | 2017-04-28 | 2018-11-01 | 江南大学 | Kit and method for detecting content of evs-trpc5 in human peripheral blood |
| CN107884567A (en) * | 2017-12-08 | 2018-04-06 | 广州源起健康科技有限公司 | A kind of magnetic bead time-resolved fluoroimmunoassay quantitatively detects Clenbuterol kit |
| CN110183474A (en) * | 2019-06-13 | 2019-08-30 | 辽宁大学 | A kind of novel fluorescence probe and preparation method thereof and in detection urine " clenbuterol hydrochloride " clenbuterol application |
| CN110183474B (en) * | 2019-06-13 | 2021-06-25 | 辽宁大学 | A new type of fluorescent probe and its preparation method and application in the detection of "clenbuterol" clenbuterol in urine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1793927A (en) | Reagent box for detecting clenbuterol hydrochloride and its detection method | |
| CN102288765B (en) | Immunofluorescence chloramphenicol detecting method based on quantum dots and special kit | |
| CN102520155B (en) | Clenbuterol hydrochloride assay kit and its preparation method and use method | |
| CN1807601A (en) | Immune colloid gold test paper strip for detecting sulfadiazine residue and its preparation method | |
| CN101545913A (en) | Chemoluminescence immunoassay measuring kit and preparation method thereof for triiodothyronine magnetic particles | |
| CN101799469A (en) | Enzyme linked immunosorbent assay kit for detecting residual clenbuterol hydrochloride and a detection method thereof | |
| CN1844926A (en) | ELISA kit for detecting Sudan red medicines and detection method thereof | |
| CN104655847A (en) | Enzyme linked immunosorbent assay kit (ELISA kit) for detecting adprin and detection method thereof | |
| CN1885039A (en) | Micro-molecule indirectly labeled dual-antigen sandwich method for determining hepatitis C virus total antibody | |
| CN1885038A (en) | ELISA kit for detecting clenbuterol and detection method thereof, and animal tissue sample preparing method before detection | |
| CN101788560B (en) | Enzyme-linked immunoassay kit for detecting residual chloramphenicol and detection method thereof | |
| CN101482562A (en) | Detection reagent kit and detection method for diethyl stilbestrol | |
| CN1268931C (en) | Reagent box and detection for ochracin A | |
| CN1888903A (en) | Enzyme-linked immune assay kit for detecting olaquindox | |
| CN101936985B (en) | Method for detecting diethylstilbestrol and special chemiluminescent immunoassay kit thereof | |
| CN1159580C (en) | Reagent for colloidal gold chromatographic analysis of SARS coronavirus antigen | |
| CN102749455B (en) | Kit for chemilumineseent quantitative immunoassay of angiotensin II and preparation method thereof | |
| CN101710117A (en) | Testing kit for enrofloxacin and testing method thereof | |
| CN100338030C (en) | Method for purifying alficetin and its special immune affinity chromatographic column | |
| CN1811440A (en) | Method for detecting Ivermectin and special enzyme-linked immune reagent kit thereof | |
| CN102262157B (en) | Quantum dot-based method for immunofluorescence of clenbuterol hydrochloride and special kit thereby | |
| CN103808921A (en) | Enzyme-linked immunosorbent assay kit for detecting residual zilpaterol and use method thereof | |
| CN1766629A (en) | An enzyme-linked immunosorbent assay kit for detecting chloramphenicol in food of animal origin | |
| CN101059514A (en) | Snake toxin antigen-antibody reaction quantitative determination method | |
| CN1712964A (en) | Specific antigenic mark for rheumatoid arthritis and its use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |